drugset

drugset / Trial / NCT02438709

Effect Observation Study of COX-2 Inhibitor to Treat Primary Hypertrophic Osteoarthropathy

NCT02438709 ↗

Phase 3 Unknown 30 enrolled Peking Union Medical College Hospital

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether COX-2 inhibitor is effective in the treatment of primary hypertrophic osteoarthropathy

Timeline

Start: 2012-12
Primary completion: 2015-07
Completion: 2016-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Etoricoxib	Small molecule	60 mg	Oral

Indications